Trials / Unknown
UnknownNCT00609089
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
A Stage 1 Study of Community Reinforcement and Family Training for Treatment Drug Abuse Treatment Retention/HIV Risk Reduction
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The planned research will adapt an intervention of known efficacy to target a new outcome of significant importance to public health. Specifically the Community Reinforcement and Family Training (CRAFT) procedures will be adapted, from reinforcing treatment entry, to reinforcing treatment retention and HIV risk behavior reduction in persons with opioid dependence who receive a Buprenorphine taper detoxification. The research plan includes three phases: 1) development of a manual guided therapy, 2) development of therapist training and fidelity measures and 3) a randomized pilot evaluation with 52 patients receiving either the new CRAFT treatment or treatment as usual.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | CRAFT-T | The Community Reinforcement and Family Training for Treatment Retention and HIV Risk Reduction treatment (CRAFT-T) was be developed in phase 1 and 2 of the current study and consists of twelve manual-guided weekly one-hour individual sessions for the concerned significant other and 2 one hour sessions for the identified patient. The intervention also allows for up to two additional sessions (total of 14 visits) to help arrange re-entry into substance abuse treatment when needed. The identified patient receives this intervention in addition to the usual services at the drug treatment program (Maryhaven). |
| BEHAVIORAL | Treatment as usual | Treatment as usual will be the normal course of treatment for concerned significant others (CSOs) in the outpatient department. |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2012-06-01
- Completion
- 2013-06-01
- First posted
- 2008-02-06
- Last updated
- 2012-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00609089. Inclusion in this directory is not an endorsement.